ConvaTec (GB:CTEC) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
ConvaTec faces a temporary setback as its InnovaMatrix® product is currently not covered by Medicare for treating diabetic foot ulcers and venous leg ulcers. Despite this, the company remains optimistic about future coverage and anticipates strong financial growth, with expected organic revenue growth and expanding operating margins in the coming years. ConvaTec continues to rely on its broad product portfolio and efficiency initiatives to drive performance.
For further insights into GB:CTEC stock, check out TipRanks’ Stock Analysis page.